References
- Wartofsky. Thyrotoxic storm. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's Thyroid. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 651–57.
- Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263–77.
- Chong HW, See KC, Phua J. Thyroid storm with multiorgan failure. Thyroid. 2010;20:333–6.
- Izumi K, Kondo S, Okada T. A case of atypical thyroid storm with hypoglycemia and lactic acidosis. Endocr J. 2009;56:747–52.
- Jiang YZ, Hutchinson KA, Bartelloni P, Manthous CA. Thyroid storm presenting as multiple organ dysfunction syndrome. Chest. 2000;118:877–9.
- Sherman SI, Simonson L, Ladenson PW. Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome? Am J Med. 1996;101:192–8.
- McKenna CJ, Codd MB, McCann HA, Sugrue DD. Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study. Am Heart J. 1998;135(5 Pt 1):833–7.
- Kantharia BK, Richards HB, Battaglia J. Reversible dilated cardiomyopathy: an unusual case of thyrotoxicosis. Am Heart J. 1995;129:1030–2.
- Ebisawa K, Ikeda U, Murata M, Sekiguchi H, Nagai R, Yazaki Y, Irreversible cardiomyopathy due to thyrotoxicosis. Cardiology. 1994;84:274–7.
- Siu CW, Zhang XH, Yung C, Kung AW, Lau CP, Tse HF. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab. 2007;92:1736–42.
- Saunders J, Mathewkutty S, Drazner MH, McGuire DK. Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms. Herz. 2008;33:184–90.
- Redgrave JN, Coutts SB, Schulz UG, Briley D, Rothwell PM. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke. 2007;38:1482–8.
- Potenza M, Via MA, Yanagisawa RT. Excess thyroid hormone and carbohydrate metabolism. Endocr Pract. 2009;15:254–62.
- Harper JA, Dickinson K, Brand MD. Mitochondrial uncoupling as a target for drug development for the treatment of obesity. Obes Rev. 2001;2:255–65.